• Explore /
  • Poster
  • / Synergistic effects of cabozantinib to temozolomide and bevacizumab in patients with heavily pretreated relapsed uterine leiomyosarcoma.

Synergistic effects of cabozantinib to temozolomide and bevacizumab in patients with heavily pretreated relapsed uterine leiomyosarcoma.

Abstract Poster

Authors

null

Sayaka Ikeda

Tama-Hokubu Medical Center, Higashimurayama, Japan

Sayaka Ikeda , Kazuya Kudoh , Naoki Sasaki , Masashi Takano , Tomoko Goto , Ryoko Kikuchi , Masaru Sakamoto , Tsunekazu Kita , Nobuyuki Susumu , Daisuke Aoki , Hiroko Kouta , Yoshihiro Kikuchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5590)

DOI

10.1200/jco.2015.33.15_suppl.5590

Abstract #

5590

Poster Bd #

148

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Effects of temozolomide and bevacizumab in patients with pretreated relapsed uterine leiomyosarcoma.

Effects of temozolomide and bevacizumab in patients with pretreated relapsed uterine leiomyosarcoma.

First Author: Naoki Sasaki

First Author: Maria Grazia Pionelli

First Author: Hiroko Matsuura

First Author: Kristine Peregrino Lacuna